Project Grant R01DK137791

Award Date 6/17/25
Completion Date 5/31/30
Dollars Obligated $465K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
This $391,250 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support research on extracellular vesicle-dependent RNA signaling in metabolism. The project aims to identify key proteins involved in the delivery of adipose microRNAs into liver cells via extracellular vesicles, and to determine if this RNA delivery mechanism is necessary for...
This federal Project Grant award, valued at $450,000.00 and awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to elucidate the roles of the lysine acetyltransferase KAT8 in adipocyte function and its impact on lipoatrophy and systemic insulin resistance. The long-term objective is to understand how adipocyte KAT8 contributes to adipose tissue function and...
This federal Project Grant award in the amount of $640,762.00 was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, with a start date of September 15, 2024 and an ultimate completion date of June 30, 2029, will fund research conducted by the Scripps Research Institute in La Jolla, California to investigate the interorgan communication mechanisms between...
This $243,590 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research at the University of Chicago to investigate the role of the protein BNIP3 in regulating lipid metabolism and fat accumulation in the liver. The research aims to elucidate the mechanisms by which BNIP3 promotes mitophagy (selective degradation of mitochondria) and...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1,618,520 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Pittsburgh. The grant, titled "Defining the Molecular Regulation and Physiological Role of a Novel Lysosomal Mechanism of Adipocyte Lipolysis," aims to investigate an alternative lysosomal pathway for fatty acid release from adipocytes during fasting. The research...
This Project Grant award for $121,875.00, awarded on April 5, 2025 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), aims to investigate the developmental origins and regulatory mechanisms of dermal adipose tissue (DWAT), a distinct and understudied component of the subcutaneous adipose depot. The research will utilize mouse models, advanced transcriptomic techniques, metabolic phenotyping, and human adipose tissue samples to address long-standing questions...
This $578,060 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to study a potential new enhancer region that activates the UCP1 gene, which is critical for thermogenesis and energy expenditure. The research will examine how this enhancer functions to increase UCP1 transcription, as well as assess its impact on thermogenesis, adiposity, and...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the CFDA program "Diabetes, Digestive, and Kidney Diseases Extramural Research" (93.847), will provide $340,175 to American University to conduct research on the effects of federal funding for obesity prevention programs on weight-related health behaviors, obesity prevalence, and obesity-related chronic conditions. The project aims to leverage variation in county and...
This Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund a $506,598.00 research project at the Harvard T.H. Chan School of Public Health from September 15, 2024 to August 31, 2025. The project aims to determine the effects of dietary fat and carbohydrate composition on fundamental energy metabolism processes, including tissue fuel selection,...
This federal Project Grant award for $373,129, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research to explore the role of mitophagy (the degradation of damaged mitochondria) in promoting tissue health and homeostasis. Specifically, the research aims to investigate the physiological functions of the two distinct forms of mitophagy - ubiquitin-dependent and receptor-dependent - in the...

This federal Project Grant award of $464,985, awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to understand the fundamental regulation of adipocyte-derived mitochondrial extracellular vesicles (mitoEVs) and their potential role in obesity-related cardiometabolic disease.

The primary objectives are to: 1) determine how the production and release of adipocyte mitoEVs is regulated under energetic stress, and 2) establish the consequences of chronically circulating adipocyte mitoEVs on obesity-related cardiometabolic disease in vivo. This research is being conducted by the Washington University, a prominent private research institution, over the period from June 17, 2025 to May 31, 2030. The findings from this project have the potential to identify adipocyte EVs and mitoEVs as viable targets for therapeutic intervention in addressing the cardio-metabolic complications of obesity.

Generated 7/1/25, 3:35 AM